Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 439

Chairman Powell and Omicron: the Grinches who stole Christmas?

Equity markets were generally chugging along quite nicely until November when news broke that a new Covid-19 variant, Omicron, had started spreading outside South Africa, grabbing global headlines and sparking fears of a new round of economy- and company-damaging restrictions.

Then on the last day of the month, US Federal Reserve Chair Powell threatened to become the ‘Grinch who stole Christmas’. He abruptly changed his tune on inflation. Powell announced he would retire the word ‘transitory’ – the word he’d been using to quash concerns about a possible sustained surge in inflation. Powell’s about-face was a hawkish signal that the monetary punchbowl that has turbocharged markets might be drained faster than expected. As a result, most equity indices fell between 0% to 4% over November.

Non-profit techs fare worst

One section of the market, ‘non-profitable’ tech companies, has been particularly severely affected. These companies entered a veritable bloodbath, slumping -13.4% for the month and taking falls from their November highs to a bear-market sized -25%.

Non-profitable tech bear market

Source: Bloomberg, Goldman Sachs Non-Profitable Tech Index

We explore the impact of Omicron, although by early December, investors were becoming more sanguine about the variant’s impact and reecouping some losses.  

Omicron – different, different, but same?

Late November and December usually have little stock-specific news. The last quarterly or six-monthly results are out of the way and investors are waiting for the next earnings results in late January and February the following year. Late in the calendar year markets are often driven by macro factors like inflation, unemployment, GDP growth and geopolitics.

Omicron is the ‘X-factor’ driving markets late this year, and experts are worried this new strain could send the COVID fight back to square one.

The excellent chart below from Nextstrain.org shows just how different Omicron is to previous variants, including Delta. It details the number of mutations to the spike protein (S1) that different variants have undergone. Omicron is in red and the most recent Delta variant in green. Different indeed!

Source: Nextstrain.org

But the growing consensus is that while Omicron may potentially be more transmissible than Delta, it may not be as severe. Early evidence also suggests that whilst existing vaccines may provide less protection against Omicron, they still guard against severe disease and booster shots may help re-establish previous protection levels.

As you can see in the chart below, the recent rise in cases in South Africa has not been accompanied by a rise in deaths as was seen in previous waves.

It is too early to be definitive, though. Omicron cases in South Africa have been disproportionately in the young and in a population with higher vaccines levels than in the past, which makes historical comparisons tricky.

Markets hate uncertainty and news on this new variant will dominate markets moves until there is greater clarity across three key areas:

  • Its transmissibility
  • Its virulence
  • The effectiveness of current and future vaccines

For equity investors, the impact of the virus on company valuations is often most directly felt through the effect of mobility restrictions on demand for companies’ goods and services. Governments will be loath to reintroduce more restrictions given what countries have already been through. However, if Omicron threatens to overwhelm health care systems investors need to be prepared for fresh measures. Some countries have already slapped restrictions on travel. 

We manage the Ophir funds so that companies in our portfolio are impacted as little as possible by virus outcomes. Examples of these businesses for our Australian equity funds includes:

  • Elders – the rural services business involved in the sale of wool, grain, seed, fertilizer and animal health products.
  • EBOS – the medical consumables and equipment company that supplies goods to hospital and pharmacies.
  • NextDC – Australia’s leading independant data centre operator that benefits as businesses move to the cloud.

Given our lack of PhD’s in virology, we are unlikely to get an ‘edge’ on the market by pricing Omicron outcomes. We remain content to maintain our edge from the bottom-up work we do in meeting with company management and others (customers, suppliers, competitors, etc) in the eco-system in which they operate.

Inflation (and rate rises) – a Scrooge-like shadow

The other main risk garnering attention for equity markets in 2021 is inflation, which is casting a Scrooge-like shadow over Christmas. 

COVID and inflation are linked at the hip, with the former in large part causing the latter. Today’s current multi-decade-high consumer price inflation levels in some major developed economies has been caused by two main influences:

First, huge fiscal stimulus by governments in response to COVID. When combined with mobility restrictions, this pent-up demand has been disproportionately spent on goods, while supply chains simply haven’t had the capacity to keep up with that demand.

Second, labour supply has taken a knock because COVID has forced some workers permanently out of the workforce and others are unwilling to come back to work yet due to virus-related health concerns.

Inflation has persisted longer than most economists predicted, including central bankers whose job it is to tame it, so many now expect the removal of rock-bottom emergency-level interest rates to be brought forward.

Earlier this year, most expected US interest rates to begin increasing only at the start of 2024. Now the consensus is steadily moving towards rates lifting off in 2022. Below we show the US government debt ‘yield curve’, or the rate of interest for lending money to the US Government for different time periods from 1 month up to 10 years. These rates have been consistently moving higher recently, particularly for short periods like the next 2-3 years.

US Government yield curve

Source: Bloomberg

Bear market bloodbath and the ‘expensive small growth’ implosion

This has created headwinds for domestically-orientated small-cap growth businesses in the US, especially ‘non-profitable tech’ companies. These up-and-coming technology-based businesses are not making profits yet or are deliberately suppressing profits to reinvest for future growth.

Some examples of more well-known names to be hit hard include, with their share price falls from their 52 weeks highs in brackets: Draft Kings (-61.2%), Pinterest (-59.9%), Lyft (-43.7%), Robinhood (-76.8%), and Docusign (-55.6%).

 

In the chart below of US small-cap growth (as proxied by the Russell 2000 Growth index in the yellow line), and non-profitable tech businesses (dark blue line), you can see steep falls over the last month or so as bond yields (red line) have continued to move higher.

Source: Bloomberg

Higher interest rates disproportionately negatively impact the valuation of businesses with the most profit growth out further into the future, and this tends to be the smaller and less profitable businesses.

The median valuation of non-profitable tech stocks has almost halved (!) from a peak this cycle of 10x Enterprise Value/Sales in March this year, to 5.6x today.

Some of our most growth-orientated and high valuation companies in our Global Opportunities Fund have had their valuations de-rate substantially – hurting performance – whilst underlying company fundamentals such as revenue growth, in general, continues to be strong and beat consensus.

The key question for us is whether there is much further to go in the valuation pull-back for the ‘growthiest’ parts of the global market, particularly the US small-cap market? The good news is that the underperformance of non-profitable tech versus Big Tech (Nasdaq) has been historically extreme recently, with the biggest gap seen in years (chart below).

Valuations in our global pond still looking ok

The reality is there is no one ‘market’, just a collection of individual companies in which we can invest. That said, the two most ‘expensive’ parts of the markets are the two pools we don’t invest in – US large caps and US Big Tech.

In the chart below, you can see that the long-term average (cyclically adjusted) price-earnings ratios of the S&P500 and the Nasdaq are well above their pre-COVID levels. Global small-mid caps (MSCI World SMID Cap), US small caps (Russell 2000) and the Australian share market (ASX200) valuations don’t look anywhere near as worrisome. 

Difficulty anticipating corrections

The uncertainty of Omicron and more recent heightened volatility can no doubt create some unease for investors. For those perpetually worried about market falls and trying to time them, the wise words of famed investor Peter Lynch often come to our minds:

“Far more money has been lost by investors preparing for corrections, or trying to anticipate corrections, than has been lost in corrections themselves.”

 

Andrew Mitchell and Steven Ng are co-founders and Senior Portfolio Managers at Ophir Asset Management, a sponsor of Firstlinks. This article is general information and does not consider the circumstances of any investor.

Read more articles and papers from Ophir here.

 

RELATED ARTICLES

Amid a tornado of headlines, where can investors find opportunity?

3 fortress growth stocks for volatile times

Australia, the Lucky Country again?

banner

Most viewed in recent weeks

Raising the GST to 15%

Treasurer Jim Chalmers aims to tackle tax reform but faces challenges. Previous reviews struggled due to political sensitivities, highlighting the need for comprehensive and politically feasible change.

7 examples of how the new super tax will be calculated

You've no doubt heard about Division 296. These case studies show what people at various levels above the $3 million threshold might need to pay the ATO, with examples ranging from under $500 to more than $35,000.

The revolt against Baby Boomer wealth

The $3m super tax could be put down to the Government needing money and the wealthy being easy targets. It’s deeper than that though and this looks at the factors behind the policy and why more taxes on the wealthy are coming.

Meg on SMSFs: Withdrawing assets ahead of the $3m super tax

The super tax has caused an almighty scuffle, but for SMSFs impacted by the proposed tax, a big question remains: what should they do now? Here are ideas for those wanting to withdraw money from their SMSF.

Are franking credits hurting Australia’s economy?

Business investment and per capita GDP have languished over the past decade and the Labor Government is conducting inquiries to find out why. Franking credits should be part of the debate about our stalling economy.

Here's what should replace the $3 million super tax

With Div. 296 looming, is there a smarter way to tax superannuation? This proposes a fairer, income-linked alternative that respects compounding, ensures predictability, and avoids taxing unrealised capital gains. 

Latest Updates

Investment strategies

9 winning investment strategies

There are many ways to invest in stocks, but some strategies are more effective than others. Here are nine tried and tested investment approaches - choosing one of these can improve your chances of reaching your financial goals.

Planning

Super, death and taxes – time to rethink your estate plans?

The $3 million super tax has many rethinking their super strategies, especially issues of wealth transfer on death. This reviews the taxes on super benefits and offers investment alternatives.

Taxation

Raising the GST to 15%

Treasurer Jim Chalmers aims to tackle tax reform but faces challenges. Previous reviews struggled due to political sensitivities, highlighting the need for comprehensive and politically feasible change.

Shares

The megatrend you simply cannot ignore

Markets are reassessing the impact of AI, with initial euphoria giving way to growing scepticism. This shift is evident in the performance of ASX-listed AI beneficiaries, creating potential opportunities.

Gold

Is this the real reason for gold's surge past $3,000?

Concerns over the US fiscal position seem to have overtaken geopolitics and interest rates as the biggest tailwind for gold prices. Even if a debt crisis doesn't seem likely, there could be more support on the way.

Exchange traded products

Is now the time to invest in small caps?

With further RBA rate cuts forecast this year, small caps may be key beneficiaries. There are quality small cap LICs and LITs trading at discounts to net assets, offering opportunities for astute investors.

Strategy

Welcome to the grey war

Forget speculation about a future US-China conflict - it's already happening. Through cyberwarfare and propaganda, China is waging a grey war designed to weaken democracies without firing a single shot.

Sponsors

Alliances

© 2025 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.